--2025/Q1-- / 300.000K--
--2024/Q4-- / 200.000K--
--2024/Q3135.290K / 242.000K--
--2024/Q2124.970K / 211.500K--
--2024/Q1116.460K / 150.000K--
Strategy
MSTR
Meta Platforms
META
Oracle
ORCL
Amazon
AMZN
Salesforce
CRM
US Stock MarketDetailed Quotes
SXTP 60 Degrees Pharmaceuticals
- 2.010
- +0.090+4.69%
Close Feb 26 16:00 ET
2.96MMarket Cap-0.12P/E (TTM)
2.090High1.881Low118.33KVolume1.980Open1.920Pre Close234.07KTurnover8.60%Turnover RatioLossP/E (Static)1.47MShares35.99452wk High-0.84P/B2.77MFloat Cap1.78052wk Low--Dividend TTM1.38MShs Float519.000Historical High--Div YieldTTM10.91%Amplitude1.780Historical Low1.978Avg Price1Lot Size
60 Degrees Pharmaceuticals Key Stats
60 Degrees Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
60 Degrees Pharmaceuticals Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data